AAAAAA

   
Results: 1-25 | 26-40 |
Results: 26-40/40
COMBINED EFFECTS OF CONCAVE AND CONVEX NONLINEARITIES IN SOME ELLIPTIC PROBLEMS
Authors: AMBROSETTI A BREZIS H CERAMI G
Citation: A. Ambrosetti et al., COMBINED EFFECTS OF CONCAVE AND CONVEX NONLINEARITIES IN SOME ELLIPTIC PROBLEMS, Journal of functional analysis, 122(2), 1994, pp. 519-543
LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP
Authors: CERVANTES F ROBERTSON JE ROZMAN C BACCARANI M TURA S GOMEZ GA BRAUN TJ CLARKSON BD PEREIRA A ZACCARIA A ZUFFA E MANDELLI F ALIMENA G MONTEFUSCO E RUSSO D FANIN R GRIGNANI F MARTELLI MF MORRA E BERNASCONI C CAJOZZO A PERONA G AMBROSETTI A LEONI P LOMBARDO M DELFINI C TORLONTANO G PORCELLINI A DEMILIO A BATTISTA R LEONI F GUGLIELMO P GIUSTOLISI R DECATALDO F NOSARI A RIZZOLI V MANGONI M CARNEVALI C LISO V SPECCHIA G BAJETTA E BROCCIA G DITUCCI A BUSINCO A BRUZZESE L ABADESA A LANZI E ALBERTI A NERI A RONCO F TONATO M GRIFONI V
Citation: F. Cervantes et al., LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP, British Journal of Haematology, 87(2), 1994, pp. 293-300
HIGH-DOSE DAUNORUBICIN (DNM) IN INDUCTION OF ADULT ALL PATIENTS - PRELIMINARY-RESULTS OF A PILOT PROTOCOL (ALLVR589)
Authors: TODESCHINI G TECCHIO C MENEGHINI V PIZZOLO G AMBROSETTI A VENERI D ZANOTTI R PERONA G
Citation: G. Todeschini et al., HIGH-DOSE DAUNORUBICIN (DNM) IN INDUCTION OF ADULT ALL PATIENTS - PRELIMINARY-RESULTS OF A PILOT PROTOCOL (ALLVR589), Blood, 84(10), 1994, pp. 10000044-10000044
PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMAS (PEL) OF HEAD AND NECK - REPORT OF 70 CASES
Authors: AMBROSETTI A PASINI F DIMARCO A SCOGNAMIGLIO F TODESCHINI G SABBIONI R MENEGHINI V PIZZOLO G
Citation: A. Ambrosetti et al., PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMAS (PEL) OF HEAD AND NECK - REPORT OF 70 CASES, Blood, 84(10), 1994, pp. 10000157-10000157
3RD-GENERATION REGIMENS ARE THE THERAPY OF CHOICE IN PATIENTS WITH MEDIASTINAL LARGE B-CELL LYMPHOMA (MLBCL) WITH SCLEROSIS
Authors: TODESCHINI G AMBROSETTI A TECCHIO C PIZZOLO G MENEGHINI V VENERI D GIOVANNINI M MENESTRINA F PINTO F FRANCHINI M PERONA G
Citation: G. Todeschini et al., 3RD-GENERATION REGIMENS ARE THE THERAPY OF CHOICE IN PATIENTS WITH MEDIASTINAL LARGE B-CELL LYMPHOMA (MLBCL) WITH SCLEROSIS, Blood, 84(10), 1994, pp. 10000165-10000165
PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION
Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E
Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML
Authors: GOBBI M TURA S RUSSO D ZUFFA E PATRIARCA F FIACCHINI M GOBBI M BACCARANI M MONTEFUSCO E MELONI G MANDELLI F ZAMAGNI MD TESTONI N ZACCARIA A FANIN R DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V DEMILIO A BATTISTA R DITUCCI A BROCCIA G BODENIZZA CA CAROTENUTO M ROTONDO G AMBROSETTI A PERONA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B MORRA E BERNASCONI C RAMBALDI A BARBUI T RONCO F NOBILE F LEONI P NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S GENTILINI I COSER P DINI D DIPRISCO U PAPINESCHI F SPREMOLLA G LIBERATI A GRIGNANI G TABILIO A MARTELLI M PARDINI S LONGINOTTI M MANGONI L RIZZOLI V GALIENI P DISPENSA E ABBADESSA A BRUZZESE L LEONI F CIOLLI S CANTONETTI M PAPA G LANDOLFI R LEONE G GALLO E PILERI A ZAGONEL V PINTO A VOLPE E DIFRANCESCO A QUAGLINO D AVANZINI P GOBBI F PAOLINO F RESEGOTTI L SAGLIO G CAMASCHELLA C MAZZA U PINOTTI G VENCO G CAPUCCI A IZZI T MORANDI S BIANCHINI E SCAPOLI GL MONACO M PIZZUTI M RICCIUTI F CAPALDI A GIOVANNELLI E
Citation: M. Gobbi et al., KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML, Leukemia & lymphoma, 11, 1993, pp. 277-280
ORAL ITRACONAZOLE PLUS NASAL AMPHOTERICIN-B FOR PROPHYLAXIS OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: TODESCHINI G MURARI C BONESI R PIZZOLO G AMADDI G AMBROSETTI A CERU S PIACENTINI I MARTINI N MONTRESOR P PERONA G
Citation: G. Todeschini et al., ORAL ITRACONAZOLE PLUS NASAL AMPHOTERICIN-B FOR PROPHYLAXIS OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, European journal of clinical microbiology & infectious diseases, 12(8), 1993, pp. 614-618
A NOTE ON THE EXISTENCE OF MULTIPLE BRAKE ORBITS
Authors: AMBROSETTI A BENCI V LONG YM
Citation: A. Ambrosetti et al., A NOTE ON THE EXISTENCE OF MULTIPLE BRAKE ORBITS, Nonlinear analysis, 21(9), 1993, pp. 643-649
IN-VITRO AMPLIFICATION OF HYPERVARIABLE DNA REGIONS FOR THE EVALUATION OF CHIMERISM AFTER ALLOGENEIC BMT
Authors: MARTINELLI G TRABETTI E ZACCARIA A FARABEGOLI P BUZZI M TESTONI N CALORI E BANDINI G ROSTI G BELARDINELLI A GASPARINI P GALAVOTTI R AMBROSETTI A TURA S PIGNATTI PF
Citation: G. Martinelli et al., IN-VITRO AMPLIFICATION OF HYPERVARIABLE DNA REGIONS FOR THE EVALUATION OF CHIMERISM AFTER ALLOGENEIC BMT, Bone marrow transplantation, 12(2), 1993, pp. 115-120
SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HODGKIN DISEASE - RELATIONSHIP WITH CLINICAL STAGE, TUMOR BURDEN, AND TREATMENT OUTCOME
Authors: AMBROSETTI A NADALI G VINANTE F CARLINI S VENERI D TODESCHINI G MOROSATO L DESABATA D CHILOSI M MAGGI E PARRONCHI P ROMAGNANI S SEMENZATO G PERONA G PIZZOLO G
Citation: A. Ambrosetti et al., SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HODGKIN DISEASE - RELATIONSHIP WITH CLINICAL STAGE, TUMOR BURDEN, AND TREATMENT OUTCOME, Cancer, 72(1), 1993, pp. 201-206
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986
Authors: TURA S FANIN R RUSSO D ZUFFA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI D ZACCARIA A DAMIANI D MICHIELI M ALIMENA G MONTEFUSCO E MANDELLI F MORRA E BERNASCONI C GUGLIELMI P CACCIOLA E BATTISTA R DINI E SPECCHIA G LISO V MAJOLINO I CARONIA F LEONI P DANIELI G NOSARI A DECATALDO F PAOLINO F RESEGOTTI L COMOTTI B BARBUI T SCAPOLI GL CASTOLDI GL PROSSOMARITI L MONTUORI R RICCARDI A ASCARI E LANDOLFI R BIZZI B LOMBARDO M TORLONTANO G LEONI F FERRINI PR SPARAVENTI G DELFINI C PAPINESCHI F SPREMOLLA G BROCCIA G NARDELLI S CICCONE F DERIU L MIRAGLIA E DEBIASE R BODENIZZA CA CAROTENUTO M ROTONDO SG GENTILINI I COSER P CAPUCCI A IZZI T LUCIANO L ROTOLI B IACOPINO P NOBILE F CANTONETTI M PAPA G PINOTTI G SALA G FOA P MAIOLO MT AVANZINI P GOBBI F DORE F PARDINI S AMBROSETTI A PERONA G DINI D LIBERATI AM MARTELLI M GRIGNANI F MONTUORO A DELAURENZI A GALLO E PILERI A GALLAMINI A BUFFA F ABBADESSA A BRUZZESE L DEROSA C CIMINO R MANGONI L RIZZOLI V PIZZUTI M RICCIUTI F GALIENI P DISPENSA E ZAGONEL V PINTO A MUSOLINO C SQUADRITO G PERRICONE R CAJOZZO A MORANDI S BIANCHINI E MILIANI A MONACO M DIFRANCESCO A QUAGLINO D ROSTI G MARANGOLO M PASINI FL DIPERRI T AGLIETTA M GAVOSTO F
Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299
THE TYPE OF BCR ABL JUNCTION DOES NOT PREDICT THE SURVIVAL OF PATIENTS WITH PH1-POSITIVE CHRONIC MYELOID-LEUKEMIA/
Authors: ZACCARIA A MARTINELLI G BUZZI M TESTONI N FARABEGOLI P ZUFFA E ZAMAGNI MD RUSSO D BACCARANI M AMBROSETTI A GUERRASIO A SAGLIO G TURA S
Citation: A. Zaccaria et al., THE TYPE OF BCR ABL JUNCTION DOES NOT PREDICT THE SURVIVAL OF PATIENTS WITH PH1-POSITIVE CHRONIC MYELOID-LEUKEMIA/, British Journal of Haematology, 84(2), 1993, pp. 265-268
Risultati: 1-25 | 26-40 |